BridgeMD
New treatment option for Oral Potentially Malignant Disorders
Official title Role of the Dentist in the Control of the Alcoholic Habit in Patients with Potentially Malignant Oral Lesions
ClinicalTrials.gov ID: NCT04584333
What this study is testing
- What it's testing
- Introduction: Alcohol is the most consumed psychoactive substance, its consumption is very prevalent and there is a low perception of the risk it poses in our society. Alcohol is a risk factor and a causal factor for multiple pathologies, including cancer and potentially malignant oral lesions (LOPM).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients with a clinical and histopathological diagnosis of oral lichen planus (OPL) and/or oral leukoplakia (LO) (in all its clinical forms) as...
- Patients over 40 years old
- Patients in follow-up, with chronic injuries, without medical and/or surgical treatment for at least 1 month
- Patients with frequent daily alcohol consumption \> 1 Standard Beverage Unit (more than two glasses of wine/beer per day or one glass of...
You likely can't join if
- Participants who do not sign the informed consent.
- Patients with a score above 20 in the AUDIT.
- Patients undergoing treatment for problems with alcohol and other drugs.
- Patients with systemic pathology associated with alcohol consumption
- Pregnant patients.
- Patients undergoing active pharmacological treatment for OPL.
See the full eligibility criteria
- Patients with a clinical and histopathological diagnosis of oral lichen planus (OPL) and/or oral leukoplakia (LO) (in all its clinical forms) as chronic LOPMs according to the WHO 2017 classification.
- Patients over 40 years old
- Patients in follow-up, with chronic injuries, without medical and/or surgical treatment for at least 1 month
- Patients with frequent daily alcohol consumption \> 1 Standard Beverage Unit (more than two glasses of wine/beer per day or one glass of liquor/distilled drink per day)
- Participants who do not sign the informed consent.
- Patients with a score above 20 in the AUDIT.
- Patients undergoing treatment for problems with alcohol and other drugs.
- Patients with systemic pathology associated with alcohol consumption
- Pregnant patients.
- Patients undergoing active pharmacological treatment for OPL.
- Patients who have undergone surgical resection and/or CO2 laser treatment for LO in the last month.
- Patients with a history of malignant oral lesions.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago de Compostela, A Coruña, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago de Compostela, A Coruña, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.